Skip to content

Press Release Details

Haemonetics to Present at the Raymond James 37th Annual Institutional Investors Conference

Mar 2, 2016

BRAINTREE, Mass., March 2, 2016 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced today that Gerry Gould, Vice President – Investor Relations, will present at the Raymond James 37th Annual Institutional Investors Conference in Orlando, FL on Wednesday, March 9, 2016 at 7:30 am Eastern time

The public may access Mr. Gould's presentation live via webcast at http://wsw.com/webcast/rj99/hae.

Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing innovative blood management solutions for customers.  Together, our devices and consumables, information technology platforms, and consulting services deliver a suite of business solutions to help our customers improve patient care and reduce the cost of healthcare for blood collectors, hospitals, and patients around the world.  Our technologies address important medical markets: blood and plasma component collection, the surgical suite, and hospital transfusion services.  To learn more about Haemonetics, visit our web site at http://www.haemonetics.com.

CONTACT:
Gerry Gould, VP-Investor Relations
Tel. (781) 356-9402
gerry.gould@haemonetics.com

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/haemonetics-to-present-at-the-raymond-james-37th-annual-institutional-investors-conference-300229851.html

SOURCE Haemonetics Corporation